Cheryl L. Willman
Cheryl Willman is a leukaemia genomics pioneer who leads Mayo Clinic's cancer centre across its three sites.
Hematopathologist whose genomic studies defined high-risk subtypes of acute lymphoblastic leukaemia, including work in Hispanic and Native American children. Previously directed the University of New Mexico cancer centre; has led Mayo Clinic Comprehensive Cancer Center since 2021.
Pages like this
not linked directly; found by shared links- PersonTodd R. Golub
Shares RNA sequencing & expression profiling, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- PersonTakashi Kohno
Shares RNA sequencing & expression profiling, Comprehensive genomic profiling.
- PersonArul M. Chinnaiyan
Shares RNA sequencing & expression profiling, Comprehensive genomic profiling.
- CompanyBostonGene
Shares RNA sequencing & expression profiling, Comprehensive genomic profiling.
- PersonStephen J. Forman
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- TargetCD7
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- PersonMark R. Litzow
Shares Mayo Clinic, Acute lymphoblastic leukaemia.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia.